Activation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast
- 1 April 1986
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 52 (1) , 1-5
- https://doi.org/10.1128/iai.52.1.1-5.1986
Abstract
The complement system plays a key role in resistance to cryptococcosis. In the present study, we examined several factors that influence the binding of C3 cleavage fragments to Cryptococcus neoformans. Binding of C3 was determined by using normal human serum supplemental with 125I-labeled C3. Incubation of encapsulated cryptococci in 20% serum led to the binding of approximately 3.2 .times. 106 molecules of C3 to each cell. The binding of C3 was markedly inhibited by heating the serum of 56.degree. C for 30 min or by chelation of the serum with EDTA. Chelation of the serum with EGTA [ethylene glycol-bis(.beta.-aminoethyl ether)-N,N,N'',N''-tetraacetic acid] reduced binding of C3 by 37%. These results indicated that activation of C3 cleavage fragments and their binding to C. neoformans was primarily dependent upon the alternative pathway. Bound C3 could be removed by incubation with 1.0 M hydroxylamine (pH 10) but not by incubation with 3.5 M NaSCN or with phosphate-buffered saline containing 0.1% sodium dodecyl sulfate. These results suggested that C3 fragments were bound to C. neoformans by ester bonds. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of C3 fragments eluted from the yeast showed the presence of protein bands consistent with the presence of iC3b. C3b was not detected on the yeast after incubation with serum for time intervals as short as 2.5 min, indicating a rapid conversion of cell-bound C3b to iC3b. These results indicate that iC3b is the ligand which most likely interacts with the phagocyte C3 receptors involved in the phagocytosis of C. neoformans.This publication has 28 references indexed in Scilit:
- Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.The Journal of Experimental Medicine, 1985
- The chemistry and biology of complement receptorsSpringer Seminars in Immunopathology, 1984
- Breakdown of C3 after complement activation. Identification of a new fragment C3g, using monoclonal antibodies.The Journal of Experimental Medicine, 1982
- Binding of C3b proceeds by a transesterification reaction at the thiolester siteNature, 1982
- Binding reaction between the third human complement protein and small moleculesBiochemistry, 1981
- Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3.The Journal of Experimental Medicine, 1981
- The physiological breakdown of the third component of human complementMolecular Immunology, 1980
- Third component of human complement: purification from plasma and physicochemical characterizationBiochemistry, 1976
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- Immunofluorescence Studies of Reactions at the Cryptococcal CapsuleThe Journal of Infectious Diseases, 1968